Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Stomach Neoplasms 6 Uterine Cervical Neoplasms 2 Non-Muscle Invasive Bladder Neoplasms 2 Carcinoma, Transitional Cell 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Cancer Recurrent 1 Metastatic HER2 Positive Gastroesophageal Junction Cancer 1 Lung Neoplasms 1 High-risk Non-muscle Invasive Bladder Cancer 1 HER2-positive Metastatic Breast Cancer 1 HER2-low Breast Cancer 1 Castration-resistant Prostate Cancer 1 Advanced Breast Cancer 1

Interventions

Bevacizumab 40 Paclitaxel 35 Carboplatin 28 pembrolizumab 21 Cyclophosphamide 15 Specimen Handling 14 Cisplatin 13 olaparib 11 Blood Specimen Collection 11 niraparib 10 fludarabine 10 Magnetic Resonance Spectroscopy 9 Drug Therapy 9 liposomal doxorubicin 8 Topotecan 8 Taxes 8 Gemcitabine 8 Biopsy 8 Fulvestrant 7 Doxorubicin 6 cemiplimab 5 abemaciclib 5 Surveys and Questionnaires 5 Standard of Care 5 Injections 5 Fluorouracil 5 Cytoreduction Surgical Procedures 5 trastuzumab deruxtecan 4 mirvetuximab soravtansine 4 aldesleukin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ovarian Neoplasms × disitamab vedotin × Clear all

NCT06540729 2025-07-08

DAB

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡